Background: Hypothyroidism among obese women is one of the concerned endocrine disorders nowadays. Data shows that at least one female member suffers in almost every family in some metro cities. Iodine deficiency was one of the main factors, but it is no longer a significant cause for two decades due to its sufficient availability. So the expected risk factors are obesity and endocrine disruptors available in foods and the environment.
Objective: The study aims to determine the association between obesity and hypothyroidism among housewives living in Kolkata. Further, to evaluate hypothyroid to the euthyroid state through endocrine disruptors free dietary intervention.
Methods: This qualitative study was based on purposive sampling, including BMI, thyroid profile tests, and relevant blood reports. The dietary intervention was considered for 120 obese hypothyroid housewives within 35-45 years in Kolkata city and peripherals. The study was conducted for March-August in 2019 with Levothyroxine treatment for the 1st three months, followed by the next three months without this medicine but only dietary interventions. SPSS version 16 has been applied for the data analysis.
Results: The study revealed no such insufficiency of supplements that raised TSH and changed normal or subnormal T4 among the participants. The correlation coefficient for BMI and hypothyroid type was r = 0.524 and r = 0.425, p=.000 (p< 0.001 or p=0.000 or p<0.0005); BMI with TSH r = 0.554 and 0.437. So there was a significant relationship between obesity and hypothyroidism in association with comorbidities. Further, nine participants became normal weight, and fourteen progressed into mild status due to dietary interventions.
Conclusions: The study showed a positive association between hypothyroidism and obesity and their comorbidities. Further, the hypothyroid diet plan devoid of endocrine disruptors worked remarkably without Levothyroxine.
Cite this article:
Swapan Banerjee, Sulagna Ray Pal. Impact of dietary intervention devoid of probable endocrine disruptors among hypothyroid obese women consuming Levothyroxine -A Case study. Research Journal of Pharmacy and Technology. 2021; 14(12):6579-6. doi: 10.52711/0974-360X.2021.01138
Swapan Banerjee, Sulagna Ray Pal. Impact of dietary intervention devoid of probable endocrine disruptors among hypothyroid obese women consuming Levothyroxine -A Case study. Research Journal of Pharmacy and Technology. 2021; 14(12):6579-6. doi: 10.52711/0974-360X.2021.01138 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-12-68
1. Kokkoris P. Pi-Sunyer FX. Obesity and endocrine disease. Endocrinol Metab Clin North Am. 2003;32(4):895-914. 10.1016/s0889-8529(03)00078-1.
2. Unnikrishnan AG. Menon UV. Thyroid disorders in India: An epidemiological perspective. Indian J Endocrinol Metab. 2011;15 (Suppl 2): S78-S81. 10.4103/2230-8210.83329.
3. Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol. 2010;316(2):165-171. 10.1016/j.mce.2009.06.005.
4. Sanyal D. Raychaudhuri M. Hypothyroidism and obesity: An intriguing link. Indian J. Endocrinol. Metab. 2016; 20(4):554. 10.4103/2230-8210.183454.
5. Usha Menon V, Sundaram KR, Unnikrishnan AG, Jayakumar RV, Nair V, Kumar H. High prevalence of undetected thyroid disorders in an iodine sufficient adult south Indian population. J Indian Med Assoc. 2009;107(2):72-77.
6. Hoermann R. Midgley JE. M Larisch R. and Dietrich JW. Recent Advances in Thyroid Hormone Regulation: Toward a New Paradigm for Optimal Diagnosis and Treatment. Frontiers in Endocrinology. 2017; 8: 364. https://doi.org/10.3389/fendo.2017.00364.
7. Anandhasayanam A. Arivudainambi T. Kannan S. and UdayaChander JSJ. Prevalence of Hypothyroidism and Its Comorbidities In Relation To the Causes and Risk Factors in Patients Undergoing Levothyroxine Therapy. Int J Pharm Sci Res.2016;7(3):1251-1257.10.13040/IJPSR.0975-8232.7(3).1251-57.
8. Buckley CD. Filer A. Haworth O. Parsonage G. Salmon M. Defining a role for fibroblasts in chronic inflammatory joint disease persistence. Ann Rheum Dis. 2004;63 Suppl 2(Suppl2): ii 92-ii95. 10.1136/ard.2004.028332.
9. Verma A. Jayaraman M. Kumar HKVS. Modi KD. Hypothyroidism and obesity. Cause or effect? Saudi Med J. 2008;29(8):1135-1138. http://europepmc.org/abstract/MED/18690306.
10. Jindal SK. Gupta D. Aggarwal AN. Jindal RC. Singh V. Study of the prevalence of asthma in adults in North India using a standardized field questionnaire. J Asthma. 2000;37(4):345-351.10.3109/02770900009055458.
11. Perros P. McCrimmon RJ, Shaw G, Frier BM. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med. 1995;12(7):622-627. 10.1111/j.1464-5491. 1995. tb00553.x.
12. Papazafiropoulou A. Sotiropoulos A. Kokolaki A. Kardara M. Stamataki P. Pappas S. Prevalence of thyroid dysfunction among greek type 2 diabetic patients attending an outpatient clinic. J Clin Med Res. 2010;2(2):75-78. 10.4021/jocmr2010.03.281w.
13. Michalaki MA. Vagenakis AG. Leonardou AS. et al. Thyroid function in humans with morbid obesity. Thyroid. 2006; 16(1):73-78. 10.1089/thy.2006.16.73.
14. Rotondi M. Leporati P. La Manna A et al. Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism?. Eur J Endocrinol. 2009;160(3):403-408.10.1530/EJE-08-0734.
15. Massart F. Ferrara P. and Saggese G. Environmental Thyroid Disruptors and Human Endocrine Health. A New Look at Hypothyroidism. 2012. 10.5772/31572.
16. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies [published correction appears in Lancet. 2004 Mar 13;363(9412):902]. Lancet. 2004; 363(9403):157-163.10.1016/S0140-6736(03)15268-3.
17. Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid. 2007;17(12):1211-1223. 10.1089/thy.2006.0235.
18. Douglas CC. Lawrence JC. Bush NC. Oster RA. Gower BA and Darnell BE. The ability of the Harris-Benedict to predict energy requirements differs with weight history and ethnicity. Obes. Res. 2008; 27(4): 194–199. 10.1016/j.nutres.2007.01.016.
19. Tonstad S. Nathan E. Oda K. Fraser G. Vegan diets and hypothyroidism. Nutrients. 2013;5(11):4642-4652. 10.3390/nu5114642.
20. Vandenberg LN. Colborn T. Hayes TB et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev. 2012;33(3):378-455.10.1210/er.2011-1050.
21. Jaszczak E. Polkowska Ż. Narkowicz S. and Namieśnik J. Cyanides in the environment-analysis-problems and challenges. Environmental science and pollution research international.2017; 24(19): 15929-15948. https://doi.org/10.1007/s11356-017-9081-7.
22. Debnath M, Mandal NC, Ray S. Effect of fungicides and insecticides on growth and enzyme activity of four cyanobacteria. Indian J Microbiol. 2012; 52(2):275-280. 10.1007/s12088-011-0212-4.
23. Unnikrishnan AG. Kalra S. Sahay RK. Bantwal G. John M. Tewari N. Prevalence of hypothyroidism in adults: An epidemiological study in eight cities of India. Indian J Endocrinol Metab. 2013; 17(4):647-652. 10.4103/2230-8210.113755.
24. Banerjee S. Uses of technologies and social media for diet and exercise awareness among obese, hypothyroid, and pre-diabetic women – A case study in West Bengal. J Xi'an Univ Archit Technol. 2020; 12(3):4682-4688. 10.37896/JXAT12.03/426.
25. Donald G. Barceloux (editor). Foodborne and Microbial Toxins. United States: Wiley Publication.2008. https://onlinelibrary.wiley.com/doi/pdf/10.1002/9780470330319.
26. Eastman CJ. Zimmermann MB. updated In Feingold KR, Anawalt B, Boyce A, et al. The Iodine Deficiency Disorders: 2020. http://www.ncbi.nlm.nih.gov/books/NBK285556/table/tyd-iodine deficiency goitrogen. Accessed on 27th November 2020.
27. Curley PA. "Dietary and Lifestyle Interventions to Support Functional Hypothyroidism." Inquiries Journal/Student Pulse.2009; 1(12). http://www.inquiriesjournal.com/a?id=91.
28. Rizzo G, Baroni L. Soy, Soy Foods and Their Role in Vegetarian Diets. Nutrients. 2018;10(1):43. doi:10.3390/nu10010043.
29. Banerjee S. Fad diets on metabolic syndrome among sedentary women — A systemic review. IP J Nutr Metab Heal Sci. 2021;4(1):34-40. https://doi.org/10.18231/j.ijnmhs.2021.006.
30. Han MA. Kim JH. Coffee Consumption and the Risk of Thyroid Cancer: A Systematic Review and Meta-Analysis. International journal of environmental research and public health.2017; 14(2):129. 10.3390/ijerph14020129.
31. Banerjee S. Interactions between common foods and drugs - a narrative review. Asian J Pharm Res. 2020; 10(3):188-194. 10.5958/2231–5691.
32. Panche AN. Diwan AD. and Chandra SR. Flavonoids: an overview. Journal of nutritional science.2016; 5: e47. doi:10.1017/jns.2016.41.
33. Murthy MB. and Murthy BK. Thyroid disruptors and their possible clinical implications. Indian journal of pharmacology.2012; 44(4), 542-543. https://www.ijp-online.com/text.asp?2012/44/4/542/99351.
34. Hruby A. Hu FB. The Epidemiology of Obesity: A Big Picture. Pharmacoeconomics. 2015;33(7):673-689. 10.1007/s40273-014-0243-x.
35. Gopalan C. Ramasastry BV. Balasubramanyam SC. Revised and updated by Narasinga Rao BS. Deosthale YG. and Pant KC. Nutritive Value of Indian Foods. Revised and Updated Edition. National Institute of Nutrition, Indian Council Medical Research, Hyderabad.1989.
36. Narasinga Rao BS. Nutrient and non-nutrient composition of Indian Foods. In BS. Narasinga Rao (Ed), Development of nutritional science in India. Allied Publishers (P) Limited India.2005; pp.274-298.
37. Seljak BK. Stibilj V. Pograjc L. Mis NF. and Benedik E. Food composition databases for effective quality nutritional care. Food Chemistry.2013; 140(3): 553-561. 10.1016/j.foodchem.2013.02.061.
38. Banerjee S. Study on Yoga Intervention along with Diet on Hypothyroidism Associated with Obesity among Sedentary Working Women in West Bengal. Kamakhya Kumar, ed. Int J Yoga Allied Sci. 2019; 8(1):18-23.
39. Green R. Milner J. Joy EJM. Agrawal S. Dangour AD. Dietary patterns in India: a systematic review. Br J Nutr. 2016; 116(1):142-148. 10.1017/S0007114516001598.
40. Banerjee S. A Study on Relationship between Hypothyroidism and Non-Alcoholic Fatty Liver Disease among Obese Women in Kolkata Intervening with Diet. Int J Res Dev. 2018; 3(10):43-48.
41. Kausar H. Rahaman MU. An Assessment of Obesity Amongst Working Women. Research J. Pharmacology and Pharmacodynamics. 2013; 5(2): 134-135. 10.5958 2321-5836.
42. Shahid S. A Study of Neurotic Depression Associated with Obesity. Int. J. Ad. Social Sciences. 2017; 5(4):202-204.
43. Anandkumar S. Chacko J. Theertha CK. Usha M. Thyroid Disorder: An Overview. Res. J. Pharmacology and Pharmacodynamics.2020; 12(1):01-04. 10.5958/2321-5836.2020.00001.4.
44. Subasree S. Prevalence of Thyroid Disorders in India: An Overview. Research J. Pharm. and Tech.2014; 7(10): 1165-1168. 10.5958/0974-360X.
45. Menon A.Thenmozhi MS. Correlation Between Thyroid Function and Obesity. Research J. Pharm. and Tech 2016; 9(10):1568-1570. 10.5958/0974-360X.2016.00307.3.
46. Thokada SS. Kandregula H. Mugada V. Prevalence of Sub-Clinical Hypothyroidism among Diabetes Mellitus Patients with Vascular Complications. Asian J. Res. Pharm. Sci. 2018; 8(4): 253-257. 10.5958/2231-5659.2018.00042.5.
47. Dhivya S. Gangopadhyay S. Kumar PS. Sarkar G. Serum creatinine and eGFR are affected in female hypothyroid patients with poor Thyroid control. Asian J. Pharm. Tech. 2020; 10(4):241-244. 10.5958/2231-5713.2020.00040.9.
48. Jenishia M. Thyroid Disorders During Pregnancy. Int. J. Nur. Edu. and Research. 2020; 8(3):391-393. 10.5958/2454-2660.2020.00084.8.
49. Kapadia KB. Shah JS. Bhatt PA. Interlinking Between Altered Thyroid State and Development of Insulin Resistance: A Review. Research J. Pharmacology and Pharmacodynamics. 2011; 3(5): 234-240. 10.5958 2321-5836.
50. Rajesh K. Mukhyaprana P. Sreedhar RP. Vasudev S. Evaluation of Covariates using Population Pharmacokinetics approach for dose Individualization of Levothyroxine in Patients with Post Thyroidectomy and 131I ablation Therapy. Research J. Pharm. and Tech 2018; 11(5):2050-2054. 10.5958/0974-360X.2018.00380.3.
51. Katolkar PP. Hirulkar RM. Baheti RJ. Meshram SS. Herbal Anti-Thyroid Drugs: An Overview. Research J. Pharm. and Tech. 2020; 13(10):5045-5051. 10.5958/0974-360X.2020.00884.7.